Amphastar Pharmaceuticals, Inc.
AMPH
$29.84
-$0.66-2.16%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.10% | -8.44% | 15.98% | 16.58% | 63.34% |
| Total Depreciation and Amortization | 9.15% | 20.90% | 36.93% | 59.51% | 90.82% |
| Total Amortization of Deferred Charges | -75.84% | -65.35% | -47.08% | -3.46% | 260.89% |
| Total Other Non-Cash Items | 38.45% | -5.76% | -69.53% | 167.19% | 5.18% |
| Change in Net Operating Assets | -64.39% | 23.28% | 39.91% | -190.99% | -154.99% |
| Cash from Operations | -24.90% | -2.64% | 16.28% | 19.08% | 62.41% |
| Capital Expenditure | -37.69% | -14.57% | -7.53% | -8.67% | -13.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 100.00% | 74.53% | 74.53% | 74.53% | 73.13% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 34.70% | 150.51% | 143.15% | -419.54% | -2,324.24% |
| Cash from Investing | 68.02% | 79.33% | 80.75% | 64.80% | 64.39% |
| Total Debt Issued | -94.23% | -98.12% | -97.82% | -98.39% | -30.19% |
| Total Debt Repaid | 99.91% | 97.42% | 97.41% | 78.30% | -273.95% |
| Issuance of Common Stock | -91.31% | -- | -- | -74.37% | -56.80% |
| Repurchase of Common Stock | -72.20% | -31.75% | -44.30% | 35.91% | -55.05% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 88.91% | 96.11% | 96.75% | 94.60% | 22.73% |
| Cash from Financing | -765.33% | -118.03% | -117.83% | -119.42% | -96.04% |
| Foreign Exchange rate Adjustments | 147.45% | 106.33% | 32.62% | -1,568.00% | -355.81% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -105.00% | -174.86% | 161.96% | -169.29% | 355.25% |